07:00 , Apr 23, 2001 |  BC Week In Review  |  Company News

Allergan, Allergan Specialty deal

Eye care and specialty pharma company AGN, which spun out ASTI in 1997, exercised its option to reacquire all of ASTI's 3.3 million shares for $21.70 per share, or $71 million in cash. The purchase...
07:00 , Apr 16, 2001 |  BC Extra  |  Company News

Allergan to acquire ASTI

Eye care and specialty pharma company AGN, which spun out Allergan Specialty Therapeutics (ASTI) in 1997, exercised its option to reacquire all of ASTI's 3.3 million shares for $21.70 per share, or $71 million in...
07:00 , Jul 10, 2000 |  BioCentury  |  Finance

Bouncers

Bouncers Company 3/10 $cls 6/30 $cls $ chg % chg Noven (NOVN) 13.750 30.063 16.313 119% Techne (TECH) 77.125 130.000 52.875 69% Alza (AZA) 36.750 59.125 22.375 61% Vertex (VRTX) 66.063 105.375 39.312 60% Dianon...
08:00 , Nov 8, 1999 |  BC Week In Review  |  Company News

Techniclone board of directors update

(Management, B9) Techniclone Corp. (TCLN), Tustin, Calif.   Business: Cancer   Resigned: Chairman Thomas Testman; president and CEO Larry Bymaster; and Rockell Hankin   Appointed: William Shepard, former president and chairman of Allergan Specialty Therapeutics Inc.,...
08:00 , Nov 1, 1999 |  BC Week In Review  |  Company News

Pharmagene, Allergan Specialty, Bayer, Janssen Pharmaceutica N.V., Novartis Pharma U.K., Nycomed Amersham plc deal

Under three separate agreements, Pharmagene provided ASTI, Janssen and Nycomed Amersham access to its PhaseZero preclinical testing service, which includes human gene expression profiling, protein localization, in vitro pharmacology and gene function studies. Separately, Pharmagene...
07:00 , Jun 1, 1999 |  BioCentury  |  Finance

Psoriasis plays

Psoriasis plays Company 5/21 close 5/28 close $ chg % chg Status MedImmune (MEDI) $55.00 $63.63 $8.63 16% I Protein Design (PDLI) $18.13 $19.63 $1.50 8% I/II Corixa (CRXA)...
07:00 , Sep 14, 1998 |  BC Week In Review  |  Company News

Techniclone board of directors update

Techniclone Corp. (TCLN), Tustin, Calif.   Business: Cancer   Appointed: William Shepherd, president and chairman of Allergan Specialty Therapeutics Inc.   Resigned: Edward Legere   ...
08:00 , Mar 16, 1998 |  BC Week In Review  |  Company News

Allergan Specialty management update

(Allergan distributes ASTI shares, B12; ASTI board appointments, see above) Allergan Specialty Therapeutics Inc. (ASTI), Irvine, Calif.   Business: Cancer, Neurological, Ophthalmic   Hired: William Shepherd as president and CEO, retired president and CEO of ...
08:00 , Mar 16, 1998 |  BC Week In Review  |  Company News

Allergan Specialty board of directors update

(Allergan distributes ASTI shares, B12; ASTI names CEO, see below) Allergan Specialty Therapeutics Inc. (ASTI), Irvine, Calif.   Business: Cancer, Neurological, Ophthalmic   Appointed: Alan Lewis, president and CEO of Signal Pharmaceuticals Inc.; Gary Neil,...